Initiating insulin in patients with type 2 diabetes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Glycemic control and blood product quality of Canadian blood donors with diabetes.Transfusion · 2026
   Article
2. Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
   Review
3. GLP-1 receptor agonist and risk of erectile dysfunction in men with type 2 diabetes: a target trial emulation.EClinicalMedicine · 2026
   Article
4. Once-weekly insulin icodec vs. daily insulin glargine in type 2 diabetes: a meta-analysis with longitudinal insights.Annals of medicine and surgery (2012) · 2025
   Review
5. Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials.Journal of the Endocrine Society · 2024
   Review
6. Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.Journal of clinical medicine · 2019
   Article
7. High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study.Acta diabetologica · 2019
   Observational
8. Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol).BMC health services research · 2019
   Article
9. Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019
   Article
10. Mobile-based insulin dose adjustment for type 2 diabetes in community and rural populations: study protocol for a pilot randomized controlled trial.Therapeutic advances in endocrinology and metabolism · 2019
    Article
11. Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2018
    Article
12. Second-Generation Insulin Analogues - a Review of Recent Real-World Data and Forthcoming Head-to-Head Comparisons.European endocrinology · 2018
    Review
13. Development and Psychometric Evaluation of the Hypoglycemia Perspectives Questionnaire in Patients with Type 2 Diabetes Mellitus.The patient · 2016
    Article
14. Concepts and clinical use of ultra-long basal insulin.Diabetology & metabolic syndrome · 2016
    Review
15. Breaking down barriers to initiating insulin: Insulin prescription pad.Canadian family physician Medecin de famille canadien · 2015
    Article
16. Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus.PloS one · 2015
    Article

Corrections and comments

• Erratum issued

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as